The respiratory tract represents a highly dynamic, expansive mucosal surface continuously exposed to airborne pathogens, particulates, and environmental allergens. Understanding the complex immunological networks that govern lung homeostasis and pathology is one of the most critical frontiers in modern medicine. While basic bench science continues to uncover intricate cellular pathways, a significant bottleneck often persists in effectively translating these molecular insights into targeted, real-world clinical interventions.

The Journal for Translational Respiratory Immunology is a peer-reviewed, open-access publication established specifically to bridge this divide. By serving as a dedicated conduit between the laboratory bench and the patient bedside, the journal provides an international platform for high-impact research detailing how innate and adaptive immune mechanisms drive pulmonary health, disease progression, and therapeutic responses.

The journal focuses heavily on mechanistic studies using human cellular models, tissue explants, innovative translational systems, and clinical cohorts. It aims to accelerate the discovery, development, and validation of novel diagnostics and disease-modifying therapies for acute and chronic respiratory conditions.